• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAFF及BAFF受体的肾组织表达与增殖性狼疮性肾炎相关。

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis.

作者信息

Marín-Rosales Miguel, Palafox-Sánchez Claudia Azucena, Franco-Topete Ramón Antonio, Carrillo-Ballesteros Francisco Josué, Cruz Alvaro, Salazar-Camarena Diana Celeste, Muñoz-Valle José Francisco, Ramos-Solano Francisco

机构信息

Departamento de Reumatología, Hospital General de Occidente, Secretaría de Salud Jalisco, Guadalajara 45170, Mexico.

Grupo de Inmunología Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.

出版信息

J Clin Med. 2022 Dec 22;12(1):71. doi: 10.3390/jcm12010071.

DOI:10.3390/jcm12010071
PMID:36614872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9821186/
Abstract

Background: The B-cell activating factor (BAFF) controls the maturation and survival of B cells. An imbalance in this cytokine has been associated with systemic autoimmunity in SLE and lupus nephritis (LN). However, few investigations have evaluated the tissular expression of BAFF in LN. This study aimed to associate BAFF system expression at the tissular level with the proliferative LN classes. Methods: The analysis included eighteen kidney tissues, with sixteen LN (class III = 5, class IV = 6, class III/IV+V = 4, and class V = 1), and two controls. The tissular expression was evaluated with an immunochemistry assay. A Cytation5 imaging reader and ImageJ software were used to analyze the quantitative expression. A p-value < 0.05 was considered significant. Results: The expressions of BAFF, A proliferation-inducing ligand (APRIL), and their receptors were observed in glomerular, tubular, and interstitial zones, with BAFF being the most strongly expressed in the overall analysis. BAFF-Receptor (BR3), transmembrane activator and CALM interactor (TACI), and B-Cell maturation antigen (BCMA) displayed higher expressions in LN class IV in all zones analyzed (p < 0.05). Additionally, a positive correlation was found between APRIL, TACI, and BCMA at the glomerular level; BCMA and APRIL in the interstitial zone; and BR3, TACI, and BCMA in the tubule (p < 0.05). Conclusions: The expression of BAFF and BAFF receptors is mainly associated with LN class IV, emphasizing the participation of these receptors as an essential pathogenic factor in kidney involvement in SLE patients.

摘要

背景

B细胞活化因子(BAFF)控制B细胞的成熟和存活。这种细胞因子的失衡与系统性红斑狼疮(SLE)和狼疮性肾炎(LN)中的系统性自身免疫有关。然而,很少有研究评估BAFF在LN中的组织表达。本研究旨在将组织水平的BAFF系统表达与增殖性LN类别相关联。方法:分析包括18个肾脏组织,其中16个为LN(III类 = 5个,IV类 = 6个,III/IV + V类 = 4个,V类 = 1个),以及2个对照。通过免疫化学分析评估组织表达。使用Cytation5成像读数器和ImageJ软件分析定量表达。p值<0.05被认为具有统计学意义。结果:在肾小球、肾小管和间质区域观察到BAFF、增殖诱导配体(APRIL)及其受体的表达,在总体分析中BAFF表达最强。在所有分析区域中,BAFF受体(BR3)、跨膜激活剂和CALM相互作用分子(TACI)以及B细胞成熟抗原(BCMA)在IV类LN中表达较高(p < 0.05)。此外,在肾小球水平,APRIL、TACI和BCMA之间存在正相关;在间质区域,BCMA和APRIL之间存在正相关;在肾小管中,BR3、TACI和BCMA之间存在正相关(p < 0.05)。结论:BAFF及其受体的表达主要与IV类LN相关,强调这些受体作为SLE患者肾脏受累的重要致病因素的参与。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/3cb908596d99/jcm-12-00071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/0435c4708a3f/jcm-12-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/6ea4140e5d25/jcm-12-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/2a681970b4ab/jcm-12-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/3cb908596d99/jcm-12-00071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/0435c4708a3f/jcm-12-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/6ea4140e5d25/jcm-12-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/2a681970b4ab/jcm-12-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/9821186/3cb908596d99/jcm-12-00071-g004.jpg

相似文献

1
Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis.BAFF及BAFF受体的肾组织表达与增殖性狼疮性肾炎相关。
J Clin Med. 2022 Dec 22;12(1):71. doi: 10.3390/jcm12010071.
2
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.中国系统性红斑狼疮患者中 BAFF/BAFF 受体的表达及其与疾病活动的相关性。
Lupus. 2010 Nov;19(13):1534-49. doi: 10.1177/0961203310375268.
3
Profile of BAFF and its receptors' expression in lupus nephritis is associated with pathological classes.狼疮性肾炎中BAFF及其受体的表达谱与病理类型相关。
Lupus. 2018 Apr;27(5):708-715. doi: 10.1177/0961203317739132. Epub 2017 Oct 31.
4
Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.狼疮性肾炎中BAFF、APRIL及其同源受体基因的表达以及作为尿液生物标志物的潜在用途。
J Transl Autoimmun. 2019 Dec 17;3:100027. doi: 10.1016/j.jtauto.2019.100027. eCollection 2020.
5
Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.在没有任何单一BAFF受体的情况下,NZM 2328小鼠发生系统性红斑狼疮。
Arthritis Rheum. 2013 Apr;65(4):1043-54. doi: 10.1002/art.37846.
6
Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.系统性红斑狼疮外周血B细胞亚群上BAFF、APRIL血清水平、BAFF-R、TACI和BCMA表达与临床表现的相关性
Lupus. 2016 May;25(6):582-92. doi: 10.1177/0961203315608254. Epub 2015 Sep 29.
7
BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.BAFF-R 和 TACI 在 CD3+T 细胞上的表达:系统性红斑狼疮中 BAFF、APRIL 与辅助性 T 细胞细胞因子谱之间的相互作用。
Cytokine. 2019 Feb;114:115-127. doi: 10.1016/j.cyto.2018.11.008. Epub 2018 Nov 19.
8
BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.BAFF 系统在系统性红斑狼疮中双阴性 2、激活幼稚和激活记忆 B 细胞中的表达。
Front Immunol. 2023 Aug 22;14:1235937. doi: 10.3389/fimmu.2023.1235937. eCollection 2023.
9
TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.TACI 缺失可预防 BAFF 过表达诱导的进行性小鼠狼疮肾炎。
Kidney Int. 2018 Oct;94(4):728-740. doi: 10.1016/j.kint.2018.03.012. Epub 2018 Jun 12.
10
Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.离散对 BAFF 受体缺陷的 NZM 2328 小鼠中系统性红斑狼疮的差异发展。
Arthritis Rheumatol. 2015 Sep;67(9):2523-35. doi: 10.1002/art.39210.

引用本文的文献

1
Protective Effects of on Podocythopathies Through B-Cell-Activating Factor Inhibition in Doxorubicin-Induced Nephrotic Syndrome Rat Model.在阿霉素诱导的肾病综合征大鼠模型中通过抑制B细胞活化因子对足细胞病的保护作用
Biomedicines. 2025 Mar 14;13(3):719. doi: 10.3390/biomedicines13030719.
2
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults.在健康成年人中进行的 povetacicept(一种增强型双重 BAFF/APRIL 拮抗剂)的首次人体、随机研究,评估其安全性、药代动力学和药效学。
Clin Transl Sci. 2024 Nov;17(11):e70055. doi: 10.1111/cts.70055.
3

本文引用的文献

1
Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients.分析 TNFSF13B 多态性和 BAFF 表达在类风湿关节炎和原发性干燥综合征患者中的作用。
Mol Genet Genomic Med. 2022 Jun;10(6):e1950. doi: 10.1002/mgg3.1950. Epub 2022 Apr 12.
2
Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis.贝利尤单抗治疗狼疮性肾炎:一项系统评价与荟萃分析。
Cureus. 2021 Dec 15;13(12):e20440. doi: 10.7759/cureus.20440. eCollection 2021 Dec.
3
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
Lupus Nephritis from Pathogenesis to New Therapies: An Update.
狼疮性肾炎:从发病机制到新疗法的研究进展。
Int J Mol Sci. 2024 Aug 18;25(16):8981. doi: 10.3390/ijms25168981.
4
Targeted therapies for lupus nephritis: Current perspectives and future directions.狼疮性肾炎的靶向治疗:当前的观点和未来的方向。
Chin Med J (Engl). 2024 Jan 5;137(1):34-43. doi: 10.1097/CM9.0000000000002959. Epub 2023 Dec 7.
5
Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis.活动期狼疮肾炎患者血清细胞因子谱的特征。
Int J Mol Sci. 2023 Oct 4;24(19):14883. doi: 10.3390/ijms241914883.
6
Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.解析狼疮肾炎患者的免疫病理机制并制定潜在的治疗策略。
Int J Mol Sci. 2023 Jun 13;24(12):10066. doi: 10.3390/ijms241210066.
新型血清和尿液生物标志物在狼疮肾炎中的预后和诊断价值:系统评价。
Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.
4
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.两年随机对照试验研究贝利尤单抗治疗狼疮肾炎。
N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180.
5
Ischemia Reperfusion Injury Triggers CXCL13 Release and B-Cell Recruitment After Allogenic Kidney Transplantation.缺血再灌注损伤会在同种异体肾移植后触发 CXCL13 的释放和 B 细胞募集。
Front Immunol. 2020 Aug 6;11:1204. doi: 10.3389/fimmu.2020.01204. eCollection 2020.
6
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.利妥昔单抗联合环磷酰胺序贯贝利尤单抗治疗狼疮肾炎的 II 期随机临床试验。
Arthritis Rheumatol. 2021 Jan;73(1):121-131. doi: 10.1002/art.41466. Epub 2020 Dec 1.
7
Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.狼疮性肾炎中BAFF、APRIL及其同源受体基因的表达以及作为尿液生物标志物的潜在用途。
J Transl Autoimmun. 2019 Dec 17;3:100027. doi: 10.1016/j.jtauto.2019.100027. eCollection 2020.
8
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.狼疮肾炎的治疗:系统文献回顾为 2019 年更新的 EULAR 和欧洲肾脏学会-欧洲透析和移植学会(EULAR/ERA-EDTA)建议提供信息。
RMD Open. 2020 Jul;6(2). doi: 10.1136/rmdopen-2020-001263.
9
Analysis of the receptor BCMA as a biomarker in systemic lupus erythematosus patients.分析系统性红斑狼疮患者中受体 BCMA 作为生物标志物的作用。
Sci Rep. 2020 Apr 10;10(1):6236. doi: 10.1038/s41598-020-63390-0.
10
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).两组西班牙裔人群(欧洲白人与拉丁美洲混血儿)的系统性红斑狼疮临床表现差异及疾病严重程度增加:来自 RELSER 登记研究的数据。
Lupus. 2020 Jan;29(1):27-36. doi: 10.1177/0961203319889667. Epub 2019 Dec 4.